These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6345013)

  • 1. A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand.
    Harinasuta T; Bunnag D; Wernsdorfer WH
    Bull World Health Organ; 1983; 61(2):299-305. PubMed ID: 6345013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand.
    Chongsuphajaisiddhi T; Sabchareon A; Chantavanich P; Singhasivanon V; Attanath P; Wernsdorfer WH; Sheth UK
    Bull World Health Organ; 1987; 65(2):223-6. PubMed ID: 3301042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria.
    Kofi Ekue JM; Ulrich AM; Rwabwogo-Atenyi J; Sheth UK
    Bull World Health Organ; 1983; 61(4):713-8. PubMed ID: 6354507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
    de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
    Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
    Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
    Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
    Silachamroon U; Krudsood S; Thanachartwet W; Tangpukdee N; Leowattana W; Chalermrut K; Srivilairit S; Wilaiaratana P; Thimasarn K; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):591-6. PubMed ID: 16124422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
    de Souza JM; Sheth UK; de Oliveira RM; Roulet H; de Souza SD
    Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
    Botero D; Restrepo M; Montoya A
    Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in Thailand.
    Boudreau EF; Pang LW; Dixon KE; Webster HK; Pavanand K; Tosingha L; Somutsakorn P; Canfield CJ
    Bull World Health Organ; 1988; 66(2):227-35. PubMed ID: 3293828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I clinical trial of mefloquine in Brazilian male subjects.
    de Souza JM
    Bull World Health Organ; 1983; 61(5):809-14. PubMed ID: 6360400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
    Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
    Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose treatment of falciparum malaria with mefloquine: field studies with different doses in semi-immune adults and children in Burma.
    Tin F; Hlaing N; Lasserre R
    Bull World Health Organ; 1982; 60(6):913-7. PubMed ID: 6218927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of artesunate and artemether in combination with mefloquine on multidrug resistant falciparum malaria in eastern Thailand.
    Thimasarn K; Sirichaisinthop J; Chanyakhun P; Palananth C; Rooney W
    Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):465-71. PubMed ID: 9561593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II clinical trial of mefloquine in Brazilian male subjects.
    de Souza JM
    Bull World Health Organ; 1983; 61(5):815-20. PubMed ID: 6360401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of falciparum malaria to different antimalarials in Myanmar.
    Ejov MN; Tun T; Aung S; Sein K
    Bull World Health Organ; 1999; 77(3):244-9. PubMed ID: 10212515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
    de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
    Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
    Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.
    Harinasuta T; Bunnag D; Lasserre R; Leimer R; Vinijanont S
    Lancet; 1985 Apr; 1(8434):885-8. PubMed ID: 2858743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.
    Ekue JM; Simooya OO; Sheth UK; Wernsdorfer WH; Njelesani EK
    Bull World Health Organ; 1985; 63(2):339-43. PubMed ID: 3893778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.